Redhill Biopharma H1 2026 EPS $0.00 And Revenue $0.00

Redhill Biopharma (NASDAQ: RDHL) reported zero earnings per share (EPS) and zero revenue for the first half of 2026. This indicates no financial activity or sales during this period.